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•  NETs are low-grade endocrine cell tumors of the GI tract which rarely 
occur in the ampulla of Vater.   
•  The small number of documented cases limits the knowledge on their 
presentation and behavior.  
•  The most common method of diagnosis is EGD with biopsies, which 
can be followed by EUS to assess local invasion.3
•  Pathologic findings consist of medium size cells with eosinophilc 
cytoplasm and central round nuclei with mild atypia and 
immunohistochemistry may show expression of chromogranin, 
synaptophysin, gastrin, somatostatin and/or neuron specific enolase.4 
•  Treatment is generally surgical resection of tumor and involved lymph 
nodes.   
•  Radical surgical resection with pancreaticoduodenectomy appears to 
be the appropriate treatment of ampullary carcinoids regardless of 
size.4 
•  It is important to keep this clinical entity in working differential 
diagnoses of abdominal pain and jaundice.   
•  As seen in our case EGD biopsies may be unrevealing necessitating 
further evaluation with EUS and core biopsies for definitive diagnosis.
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Figure 1: CT of the Abdomen and Pelvis showing 
an abnormal round enhancing lesion in the 
ampullary region possibly measuring up to 16 mm.
Figure 2 
•  Carcinoid tumors of the Ampulla of Vater 
are rare low-grade, well differentiated 
tumors.  
•  They account for less than 1% of all 
gastrointestinal neuroendocrine tumors 
(NETs) and less than 2% of all tumors in 
the ampullary region.1
•  The most common presenting 
symptoms are jaundice and non-
specific abdominal discomfort.  
•  The recognition of these tumors is 
important, as historically patients with 
ampullary NETs have been more likely 
to develop metastases at smaller sizes 
and higher mortality than patients with 
duodenal NETs.2  
•  We present a case of ampullary 
carcinoid found in a patient with non-
specific abdominal pain.
•  A 52 year old female presented with two years of epigastric pain and weight loss.  The pain was predominantly nocturnal and associated 
with cramping.  It would wake her from sleep, and cause nausea and vomiting.  A trial of PPI was ineffective. 
•  CT Scan Abdomen and Pelvis: Abnormal round enhancing lesion in the ampullary region measuring 16mm with dilation of the 
extrahepatic biliary system.  
•  EGD: Confirmed a subepithelial appearing ampullary mass.  Biopsy was negative for adenoma.  
•  EUS: Given the clinical suspicion for malignancy she underwent EUS.  Showed a subepithelial ampullary mass measuring 18mm in 
diameter without bile duct obstruction.  The mass was hypoechoic, with a thick rimmed submucosal border.  Fine needle biopsies using 19 
and 22-guage shark core needles were obtained.  Cytology was diagnostic for ampullary carcinoid.  
•  Cytology: Showed the tumor was AE1/AE3 positive, CD45 negative, synaptophysin positive, chromogranin negative, CD56 positive, and 
Ki-67 involving <5% of tumor cells confirming a well-differentiated neuroendocrine tumor (typical carcinoid tumor).  
•  She underwent duodenotomy with resection of ampullary tumor, and biliary sphicteroplasty by surgical oncology.
•  Pathology: Neuroendocrine tumor, well differentiated (carcinoid tumor) 1.5 x 1.4 x 1.0 cm greatest dimensions, ampulla of Vater.  Tumor 
predominantly involves duodenal wall, duodenal submucosa and focally duodenal mucosa.  Tumor focally involves deep margin of resection 
and focally involves lateral margin of resection. TNM tumor stage: pT2, pNX.
•  A repeat EUS was performed four months after surgery with no evidence of residual lesion, and biopsies of the involved site were normal.
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